C71T
CANCELLED SECTION 71
16/01/2026
Voltar para busca
Dado oficial do USPTO
CYTOTUNE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
10/02/2026
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
08/08/2018
Data de registro
02/07/2019
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/01/2026
Última transação
10/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Ibaraki, JP
Examinador
BUTTON, JENNIFER JO
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
ID Pharma Co., Ltd.
Representantes
Stacey R. Halpern KNOBBE MARTENS OLSON & BEAR LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicalspolypeptides for in vitro and in vivo scientific and research use; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific researchreagentscosmeticspharmaceuticals
Classe 5
Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancercritical limb ischemiacystic fibrosisretinitis pigmentosaAIDSinfluenzaAlzheimer's disease; preparations for gene therapyintroducing genes to human and animal cellstissuesorgans and living bodiesgrowth media for medical purposes; vaccines; gene vaccines; vectors for introducing genes to human and animal cellstissuesorgans and living bodiesgrowth media for medical usefor gene therapy
Classe 42
Testinginspectionresearchdevelopment of pharmaceuticalscosmeticsfoodstuff; testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy; testinginspectionresearchdevelopment of vaccines; testinginspectionresearchdevelopment of recombinant proteins; medicalchemicalbiochemicalbiological and bacteriological research and functional analysis of genes or proteins; testinginspectionresearch related to technologies for manufacturing genetically engineered animalsplantsvectors; testinginspectionresearchdevelopment of vector technologiesmedical and scientific research in the field of genetics and genetic engineering; testinginspectionresearch on agriculturelivestock breedingfisheries; testinginspectionresearchdevelopment of chemicals for life science
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/07/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
14/09/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/12/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/10/2019
FIMP
FINAL DISPOSITION PROCESSED
21/10/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/07/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
10/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/04/2019
PUBO
PUBLISHED FOR OPPOSITION
16/04/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/03/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/02/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
20/02/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/02/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/02/2019
RFNP
REFUSAL PROCESSED BY IB
05/01/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/12/2018
RFRR
REFUSAL PROCESSED BY MPU
11/12/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/11/2018
CNRT
NON-FINAL ACTION WRITTEN
27/11/2018
DOCK
ASSIGNED TO EXAMINER
26/11/2018
MAFR
APPLICATION FILING RECEIPT MAILED
16/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/10/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/10/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
04/10/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CYTOTUNE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.